Concepedia

Mengjie Yao

MY

Statistics

Publications

3

Citations

49

H-Index

3

Active since

2008

Affiliations

Sanofi (Switzerland)(Current)

Sanofi (United States)

Massachusetts General Hospital

Harvard University

Hammersmith Hospital

Mengjie Yao is an author at Sanofi (Switzerland) specializing in pharmacotherapy, clinical trials, and medicine.

Top concepts

Publications per year

2008–2025

3

Publications

3

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

David J. Kuter, Waleed Ghanima, Nichola Cooper et al. · Blood · 2025 · 27 citations · Full text

1000 A STUDY OF TELAPREVIR (TVR) WITH PEGINTERFERON ALFA-2A (P) AND RIBAVIRIN (R) IN SUBJECTS WITH WELL-DOCUMENTED PRIOR P/R NULL RESPONSE, NON-RESPONSE OR RELAPSE: PRELIMINARY RESULTS

F. Poordad, M. Shiffman, K.E. Sherman et al. · Journal of Hepatology · 2008 · 12 citations · Full text

, , +5

Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study

Nichola Cooper, A.J. Gerard Jansen, Robert Bird et al. · American Journal of Hematology · 2025 · 10 citations · Full text

1–3 of 3